Neurosense Therapeutics Ltd
Change company Symbol lookup
Select an option...
NRSN Neurosense Therapeutics Ltd
ACNT Ascent Industries Co
FATH Fathom Digital Manufacturing Corp
PAYX Paychex Inc
WAVD Wavedancer Inc
RNXT RenovoRx Inc
GBNY Generations Bancorp NY Inc
POL Polished.Com Inc
MDGS Medigus Ltd
GTH Genetron Holdings Ltd
Go

Health Care : Biotechnology | Small Cap Growth
Based in Israel

NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Price: Delayed
$0.72

Day's Change: -0.03 (-4.00%)

Bid: --

Ask: --

B/A Size: --

Day's High: 0.7641

Day's Low: 0.69

Volume (Heavy Day) Today's volume of 26,834 shares is on pace to be much greater than NRSN's 10-day average volume of 30,632 shares.: 26,834

Unable to locate that news article. Back to news results

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and